Open registration: asset readiness for financing and BD, with Joy Wang, August 22
Episode 2 of NAPPA Healthcare & Biopharma Insights asks whether your asset is ready for financing or BD — and how to translate broad buyer interest into concrete requirements.
NAPPA’s thought-leadership webinar series — NAPPA Healthcare & Biopharma Insights — continues on Saturday, August 22, 2026, 8:00–9:00 PM ET with Episode 2: Beyond the Shopping List: Is Your Asset Ready for Financing or BD?
The episode is led by Dr. Joy Wang (PhD, MBA), NAPPA Strategic Advisor, a former senior leader at Novartis/Sandoz, Eli Lilly, Baxter, and Dendreon with deep expertise in portfolio strategy and decision frameworks across neuroscience, oncology, and cell & gene therapy.
What’s covered
- Translating broad buyer interest into concrete asset requirements
- Matching disease, patient population, and development path
- Building the evidence package financing and BD partners expect
- Evaluating an asset’s true competitive advantage
- Real-world cross-border deal-making and case studies
Register
Registration is free for NAPPA members and qualified industry guests. Seats are limited; join details are sent by email after registering.